Anmeldung erfolgt in Kürze...
Details werden geladen...
Dianthus Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4) | The Manila Times
NEW YORK and WALTHAM, Mass., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases, today announced that it granted equity awards on August 3, 2026, to six newly-hired, non-executive employees. The inducement grants were approved by the Company's independent Compensation Committee and were made as material inducements to acceptance of employment with Dianthus in accordance with Nasdaq Listing Rule 5635(c)(4).
Ähnliche Seiten
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/06/03/tmt-newswire/globenewswire/dianthus-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635c4/2357294
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/08/04/tmt-newswire/globenewswire/damora-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635c4/2397417Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/07/07/tmt-newswire/globenewswire/xilio-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635c4/2379369Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/07/25/tmt-newswire/globenewswire/dyne-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/2391292Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/07/02/tmt-newswire/globenewswire/damora-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635c4/2377101